湖北宜化(000422.SZ)半年度預盈7億-7.5億元 同比扭虧為盈
格隆匯7月13日丨湖北宜化(000422.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤7億-7.5億元,上年同期虧損27077.63萬元;扣除非經常性損益後的淨利潤6億元-6.5億元,上年同期虧損43456.76萬元。
2021年上半年,公司加強生產系統調度管理,安全環保整體受控,生產設備高效運行,裝置負荷水平穩步提高;公司搶抓市場機遇,適時調整經營策略,主導產品聚氯乙烯、磷酸二銨、尿素銷售價格上漲,公司同比實現扭虧為盈,盈利創半年度歷史最好水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.